Bone and soft tissue sarcomas, tumors of the skinBone and soft tissue sarcomas, tumors of the skinСаркомы костей, мягких тканей и опухоли кожи2219-46142782-3687Publishing House ABV Press470EXPERIMENTAL ONCOLOGYЭКСПЕРИМЕНТАЛЬНАЯ ОНКОЛОГИЯThe use of autologous dendritic cell vaccine in the treatment of chondrosarcomas: a clinical caseВакцина на основе аутологичных дендритных клеток в лечении хондросарком: клинический случайKomarovU. I.КомаровЮ. И.
Russian Federation

St-Petersburg

г. Санкт-Петербург

md.komarov@gmail.comSemenovaA. I.СеменоваА. И.
Russian Federation

St-Petersburg

г. Санкт-Петербург

BalduevaI. A.БалдуеваИ. А.
Russian Federation

St-Petersburg

г. Санкт-Петербург

NekhaevaT. L.НехаеваТ. Л.
Russian Federation

St-Petersburg

г. Санкт-Петербург

NovikA. V.НовикА. В.
Russian Federation

St-Petersburg

г. Санкт-Петербург

LatipovaD. H.ЛатиповаД. Х.
Russian Federation

St-Petersburg

г. Санкт-Петербург

ProcenkoS. A.ПроценкоС. А.
Russian Federation

St-Petersburg

г. Санкт-Петербург

N.N. Petrov Research Institute of oncologyФГБУ «НИИ онкологии им. Н.Н. Петрова» Минздрава России260620146251522601202226012022Copyright ©; 2014, Komarov U.I., Semenova A.I., Baldueva I.A., Nekhaeva T.L., Novik A.V., Latipova D.H., Procenko S.A.Copyright ©; 2014, Комаров Ю.И., Семенова А.И., Балдуева И.А., Нехаева Т.Л., Новик А.В., Латипова Д.Х., Проценко С.А.2014Komarov U.I., Semenova A.I., Baldueva I.A., Nekhaeva T.L., Novik A.V., Latipova D.H., Procenko S.A.Комаров Ю.И., Семенова А.И., Балдуева И.А., Нехаева Т.Л., Новик А.В., Латипова Д.Х., Проценко С.А.https://creativecommons.org/licenses/by/4.0https://sarbon.abvpress.ru/jour/article/view/470

Soft tissue sarcomas belong to a rare group of highly malignant tumors that respond poorly to chemotherapy. A case of a 50-year-old male patient suffering from a tibial chondrosarcoma of the soft tissues is presented; the disease progression after first-line chemotherapy was revealed and treatment with autologous dendritic cell vaccine was initiated. During vaccine treatment for 19 months the patient’s condition is stable. his treatment continues.

Саркомы мягких тканей – редкая группа высокозлокачественных заболеваний, плохо отвечающих на химиотерапию. Представлен случай пациента 50 лет, страдающего хондросаркомой мягких тканей голени, у которого было выявлено прогрессирование заболевания после первой линии химиотерапии и начата терапия аутологичной дендритноклеточной вакциной. На фоне лечения вакциной на протяжении 19 мес у больного сохраняется стабилизация заболевания. Лечение продолжается.

soft tissue sarcomachondrosarcomaimmunotherapyvaccinedendritic cellsсаркома мягких тканейхондросаркомаиммунотерапиявакцинадендритные клетки1. Fletcher C., D.M., Bridge J.A., Hogendoorn P., Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 2013, v. 5, 4th Edition.Fletcher C., D.M., Bridge J.A., Hogendoorn P., Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 2013, v. 5, 4th Edition.2. Jemal A., Siegel R., Ward E. et al. Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. 2007, v. 57, No. 1, p. 43-66.Jemal A., Siegel R., Ward E. et al. Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. 2007, v. 57, No. 1, p. 43-66.3. Bramwell V.H., Anderson D., Charette M.L. et al. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline. Sarcoma. 2000, v. 4, p. 103-112.Bramwell V.H., Anderson D., Charette M.L. et al. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline. Sarcoma. 2000, v. 4, p. 103-112.4. Karavasilis V., Seddon B.M., Ashley S. et al. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Cancer. 2008, v. 112, No. 7, p. 1585-1591.Karavasilis V., Seddon B.M., Ashley S. et al. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Cancer. 2008, v. 112, No. 7, p. 1585-1591.5. Qiu M.Z., Xu F., Wang S.S. et al. Responses of 109 adult soft tissue sarcoma patients to chemotherapy. Chinese Journal of Cancer. 2007, v. 26, No. 12, p. 1344-1349.Qiu M.Z., Xu F., Wang S.S. et al. Responses of 109 adult soft tissue sarcoma patients to chemotherapy. Chinese Journal of Cancer. 2007, v. 26, No. 12, p. 1344-1349.6. Li E.X., Zhang Y.T., Shang J.T. et al. Effect of modified MAID regimen for patients with advanced soft tissue sarcoma. Chinese Journal of Cancer. 2006, v. 25, No. 8, p. 1048-1051.Li E.X., Zhang Y.T., Shang J.T. et al. Effect of modified MAID regimen for patients with advanced soft tissue sarcoma. Chinese Journal of Cancer. 2006, v. 25, No. 8, p. 1048-1051.7. Lee S.H., ChangM.H., Baek K.K. et al. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patient. Oncology. 2011, v. 80, No. 3-4, p. 257-261.Lee S.H., ChangM.H., Baek K.K. et al. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patient. Oncology. 2011, v. 80, No. 3-4, p. 257-261.8. Italiano A., Mir O., Cioffi A. et al. Advanced chondrosarcomas: role of chemotherapy and survival. Annals of Oncology. 2013, v. 24, No. 11, p. 2916-2922.Italiano A., Mir O., Cioffi A. et al. Advanced chondrosarcomas: role of chemotherapy and survival. Annals of Oncology. 2013, v. 24, No. 11, p. 2916-2922.9. Нехаева Т.Л., Данилова А.Б., Балдуева И.А. Лабораторный мониторинг иммунологической эффективности вакцин на основе аутологичных дендритных клеток (ДК) у больных меланомой кожи. Российский иммунологический журнал. 2013, т. 7 (16), № 2-3, с. 345.Нехаева Т.Л., Данилова А.Б., Балдуева И.А. Лабораторный мониторинг иммунологической эффективности вакцин на основе аутологичных дендритных клеток (ДК) у больных меланомой кожи. Российский иммунологический журнал. 2013, т. 7 (16), № 2-3, с. 345.10. Otavia L.C., Chen Y.T. Cancer/testis (CT) antigens: Potential targets for immunotherapy. Cancer Science. 2009, v. 100, No. 11, p. 2014-2021.Otavia L.C., Chen Y.T. Cancer/testis (CT) antigens: Potential targets for immunotherapy. Cancer Science. 2009, v. 100, No. 11, p. 2014-2021.11. Stevenson B.J., Iseli C., Panji S. et al. Rapid evolution of cancer/testis genes on the X chromosome. BMC Genomics. 2007, v. 8, p. 129-139.Stevenson B.J., Iseli C., Panji S. et al. Rapid evolution of cancer/testis genes on the X chromosome. BMC Genomics. 2007, v. 8, p. 129-139.